finanzen.net
25.06.2019 16:51
Bewerten
(0)

CannabCo Colombia to supply $70+ Million per year, THC/CBD oil to the medical Cannabis market

BOGOTA, Colombia, June 25, 2019 /CNW/ - CannabCo Pharmaceutical Corp. Colombia S.A.S. (CannabCo Colombia), a Colombia based cannabis cultivator and manufacturer of medical cannabis products, is pleased to announce that it has signed an LOI for the provisioning of 7000 kg per annum of non psychoactive (<1% THC), and 5000 kg per annum of psychoactive cannabis oil in a variety of formats.  Products would include oil in 30-60 ml bottles of varying concentrations, capsules, and topical creams both in CBD (non psychoactive) and THC/CBD (psychoactive) formats.

CannabCo Colombia S.A.S. (CNW Group/CannabCo Pharmaceutical Corp. Colombia S.A.S)

The LOI represents the initial production on an annual supply agreement and is estimated in value to be in excess of $70MM USD per annum.  Parties intend to increase allocation and supply based on market development in the targeted region.

Production will occur in Colombia at CannabCo's extraction, production and processing facility located 30 minutes outside of the country's capital city of Bogota.

"We are very excited to be part of Colombia's efforts to become the world leader in medical cannabis supply" said Joseph Palumbo, the country general manager.  "We have been inundated with supply requests for a market that is grossly underserviced and under-producing currently, and we are looking forward to ramping up to meet the demand over the next few years.  We believe that Colombia with its perfect growing climate and dedication to the medical cannabis market will be the primary source of medical cannabis on a global scale."

CannabCo could not be more pleased with the supply agreement or its decision to enter the Colombian cannabis market. "With its near perfect growing conditions for cannabis, abundant and educated low cost labour force, and already established agricultural footprint, Colombia is the perfect place for our cannabis cultivation and product manufacturing efforts" said Joseph.

Currently Colombia has made great strides in setting up the infrastructure to meet the global demand for medical cannabis oil, however even with the enormous strides made by CannabCo and other Colombia operations; it will be many years before production reaches capacity to make a dent in global demand.  And with new markets opening up frequently, this supply gap keeps widening.  Experts estimate that Colombia may eventually supply a significant percentage of the world's demand for cannabis oil and medical cannabis derivative products, both psychoactive and non-psychoactive (CBD).

About CannabCo Pharmaceutical Corp. Colombia S.A.S.

CannabCo Colombia is a Colombia based full service cannabis company with cultivation projects in multiple regions across the country.  The company's primary extraction plant is located 30 minutes outside the capital city of Bogota.  The company will process both psychoactive and non-psychoactive cannabis and hemp flower for the production of THC and CBD oil for the medical cannabis market.  The Company's state of the art production facilities will have the capability of producing a wide range of end products to meet emerging market supply requirements for Colombia's evolving Cannabis industry, as well as global export.  The facility is pursuing EU GMP status allowing access to the underserviced global pharmaceutical market.  The company currently has multiple social projects as part of its ethical standards and is committed to the highest quality production of medical grade cannabis products in the industry. The company is vertically integrated controlling all aspects of cultivation, extraction, product manufacturing, and distribution of its medical products allowing it full control over the high quality of its end products.  The company intends to be the largest producer and manufacturer of THC/CBD based products on a global scale utilizing Colombia as its operating base.

Forward Looking Statements
This press release may contain certain "forward-looking information" and "forward-looking statements" within the meaning of applicable securities legislation. All information contained herein that is not historical in nature may constitute forward-looking information. Forward-looking statements may be identified by  statements containing the words "believes", "anticipates", "plans", "intends", "will", "should", "expects", "continue", "estimate", "forecasts" and other similar expressions. Actual results and developments may differ materially from those contemplated by these statements. Although CannabCo Colombia believes that the expectations reflected in forward-looking statements in this press release are reasonable, there can be no assurance that such statements will prove to be accurate. Future events and results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements in this press release.

SOURCE CannabCo Pharmaceutical Corp. Colombia S.A.S

Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX beendet Handel fester -- Dow stabil -- Goldman Sachs empfiehlt Halbleiterwerte zum Kauf -- Continental, Jungheinrich, Dürr, KlöCo mit Gewinnwarnung -- Wirecard, EVOTEC, Bayer, Infineon im Fokus

S&T AG beschließt neues Aktienrückkaufprogramm. TRATON-Aktien rutschen auf neues Tief. Software AG-Aktien stabilisieren sich nach Kursrutsch. NORMA-Aktie fällt unter 30-Euro-Marke. Hyundai profitiert von Nachfrage nach Stadtgeländewagen.

Die 5 beliebtesten Top-Rankings

Die 12 toten Topverdiener 2019
Diese Legenden sind die bestbezahlten Toten der Welt
Das hat sich geändert
Diese Aktien hat George Soros im Depot
Big-Mac-Index
In welchen Ländern kostet der Big Mac wie viel?
Die Länder mit den größten Goldreserven 2019
Wer lagert das meiste Gold?
In diesen Berufen bekommt man das niedrigste Gehalt
Welche Branchen man besser meiden sollte.
mehr Top Rankings

Umfrage

Verteidigungsministerin Annegret Kramp-Karrenbauer will eine deutliche Steigerung der deutschen Rüstungsausgaben. Unterstützen Sie diese Forderung?

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Wirecard AG747206
Deutsche Bank AG514000
Daimler AG710000
NEL ASAA0B733
Infineon AG623100
Amazon906866
Microsoft Corp.870747
BayerBAY001
TeslaA1CX3T
Apple Inc.865985
BASFBASF11
ProSiebenSat.1 Media SEPSM777
EVOTEC SE566480
SAP SE716460
CommerzbankCBK100